Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Nov 13, 2026, 4:00 PM EST
19.47
+0.05 (0.26%)
After-hours: Nov 13, 2026, 7:30 PM EST
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.19 billion as of November 13, 2026. It is the 8,990th most valuable company in the world and the 2,106th biggest in the United States. Its market cap has increased by 523.30% in one year.
Market Cap
1.19B
Enterprise Value
714.31M
1-Year Change
523.30%
Global Rank
Country Rank
#2,106 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $1.19B, a decrease of -8.16%. That is a compound annual growth rate of -1.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.19B | 135.57% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kardigan | 1.29B |
| UroGen Pharma | 1.28B |
| Nektar Therapeutics | 1.28B |
| Omeros | 1.27B |
| Savara | 1.25B |
| Alpha Tau Medical | 1.24B |
| Silence Therapeutics | 1.23B |
| Inhibrx Biosciences | 1.23B |